GNLX
HEALTHCAREGenelux Corp
$2.87+0.10 (+3.61%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving GNLX Today?
No stock-specific AI insight has been generated for GNLX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.29$8.54
$2.87
Fundamentals
Market Cap$129M
P/E Ratio—
EPS$-0.86
Dividend Yield—
Dividend / Share—
ROE-1.7%
Profit Margin—
Debt / Equity—
Trading
Volume212K
Avg Volume (10D)—
Shares Outstanding44.8M
GNLX News
18 articles- Genelux Corporation Reports First Quarter Financial Results and Provides Business UpdatesYahoo Finance·May 7, 2026
- Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdatesYahoo Finance·Mar 19, 2026
- Genelux Corporation to Participate in Upcoming ConferencesYahoo Finance·Feb 18, 2026
- Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan PartnersYahoo Finance·Jan 12, 2026
- Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common StockYahoo Finance·Jan 8, 2026
- Genelux Corporation Announces Proposed Public Offering of Common StockYahoo Finance·Jan 7, 2026
- Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer TrialsYahoo Finance·Jan 5, 2026
- Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical OfficerYahoo Finance·Jan 2, 2026
- Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare ConferenceYahoo Finance·Nov 26, 2025
- Institutions along with retail investors who hold considerable shares inGenelux Corporation (NASDAQ:GNLX) come under pressure; lose 16% of holdings valueYahoo Finance·Nov 20, 2025
- Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business UpdatesYahoo Finance·Nov 5, 2025
- Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth?Yahoo Finance·Oct 5, 2025
- Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment ConferenceYahoo Finance·Sep 2, 2025
- Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business UpdatesYahoo Finance·Aug 7, 2025
- 3 Promising Penny Stocks With Market Caps Under $200MYahoo Finance·Jul 15, 2025
- Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business DevelopmentYahoo Finance·Jul 7, 2025
- June 2025's Promising Penny Stocks For Savvy InvestorsYahoo Finance·Jun 16, 2025
- Genelux Corporation (GNLX) Upgraded to Buy: Here's What You Should KnowYahoo Finance·Jun 2, 2025
All 18 articles loaded
Price Data
Open$2.88
Previous Close$2.77
Day High$2.97
Day Low$2.72
52 Week High$8.54
52 Week Low$2.29
52-Week Range
$2.29$8.54
$2.87
Fundamentals
Market Cap$129M
P/E Ratio—
EPS$-0.86
Dividend Yield—
Dividend / Share—
ROE-1.7%
Profit Margin—
Debt / Equity—
Trading
Volume212K
Avg Volume (10D)—
Shares Outstanding44.8M
About Genelux Corp
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The company is headquartered in Westlake Village, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—